TipRanks
Go Ultimate55% OFF

Lifeline Biotechnologies (LLBO) Financial Statements

Lifeline Biotechnologies Financial Overview

Lifeline Biotechnologies's market cap is currently $1.30M. The company's EPS TTM is ―; its P/E ratio is -38.68; Lifeline Biotechnologies has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 18Dec 17
Income Statement
Total Revenue$ 0.00$ 350.00K
Gross Profit$ 0.00$ 349.37K
Operating Income$ -43.39K$ 241.91K
EBITDA$ -43.39K$ 242.54K
Net Income$ -43.39K$ 241.91K
Balance Sheet
Cash & Short-Term Investments$ 415.00$ 345.00
Total Assets$ 440.99K$ 503.37K
Total Debt$ 327.12K$ 383.50K
Net Debt$ 326.70K$ 383.16K
Total Liabilities$ 385.79K$ 404.78K
Stockholders' Equity$ 55.20K$ 98.59K
Cash Flow
Free Cash Flow$ 139.82K$ 45.22K
Operating Cash Flow$ 139.82K$ 45.22K
Investing Cash Flow$ -83.37K$ 0.00
Financing Cash Flow$ -56.38K$ -49.71K

Currency in USD

Lifeline Biotechnologies Earnings and Revenue History

-200K0200K400K68 %69 %70 %71 %EarningsProfit Margin20172018RevenueEarningsProfit Margin

Lifeline Biotechnologies Debt to Assets

0200K400K600K80 %84 %88 %92 %LiabilitiesDebt to Assets20172018AssetsLiabilitiesDebt to Assets

Lifeline Biotechnologies Cash Flow

-100K-50K050K100K150K200K20172018OperatingInvestingFinancing

Lifeline Biotechnologies Forecast EPS vs Actual EPS